Drug Trial Radar · NCT07095465
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
126
Planned (sponsor's estimate)
Start
Nov 14, 2025
Primary completion
Feb 2029
Study completion Mar 2029
Sponsor
- Lead sponsor
- ACADIA Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 31, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 55 years, up to 84 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A 52-Week, Phase 3, Open-Label Extension Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)
Conditions
- Lewy Body Dementia Psychosis
Interventions
ACP-204Drug
Provided as 1 capsule, to be taken orally once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects who experience treatment-emergent adverse events (TEAEs)Time frame: 52 weeks
Locations
36 sites in 6 countries. Site status is shown where the registry gives one.
ATP Clinical Research Inc.
Irvine, California · Recruiting
Georgetown University
Washington D.C., District of Columbia · Recruiting
Humanity Clinical Research, Corp
Aventura, Florida · Recruiting
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida · Recruiting
K2 Summit Research
Lady Lake, Florida · Recruiting
Homestead Associates in Research Inc
Miami, Florida · Recruiting
Advanced Clinical Research Network, Corp
Miami, Florida · Recruiting
MediClear Medical & Research Center, Inc.
Miami, Florida · Recruiting
Health Synergy Clinical Research, LLC
West Palm Beach, Florida · Recruiting
Hawaii Pacific Neuroscience
Honolulu, Hawaii · Recruiting
University of Kansas Medical Center Research Institute Inc.
Kansas City, Kansas · Recruiting
Parkinson's Disease and Movement Disorders Center of Boca Raton d/b/a Parkinson's Research Center of America-Long Island
Commack, New York · Recruiting
The Ohio State University, Energy Advancement and Innovation Center
Columbus, Ohio · Recruiting
The Movement Disorder Clinic of Oklahoma
Tulsa, Oklahoma · Recruiting
Horizon Clinical Research Group
Cypress, Texas · Recruiting
The University of Texas Health Science Center San Antonio
San Antonio, Texas · Recruiting
R and H Clinical Research
Stafford, Texas · Recruiting
Virginia Commonwealth University (a public institution of higher education)
Richmond, Virginia · Recruiting
EvergreenHealth
Kirkland, Washington · Recruiting
Ambulatory for Individual Practice for Specialized Medical Care in Psychiatry - Dr Ivo Natsov
Cherven Bryag, Bulgaria · Recruiting
DCC "Sv. Vrach and Sv. Sv. Kuzma and Damyan", OOD
Sofia, Bulgaria · Recruiting
UMHAT "Alexandrovska" EAD
Sofia, Bulgaria · Recruiting
DCC Mladost M- Varna, OOD
Varna, Bulgaria · Recruiting
Fakultni Nemocnice u sv. Anny v Brne
Brno, Czechia · Recruiting
NEUROHK s.r.o. Poliklinika Chocen a.s.
Choceň, Czechia · Recruiting
Vestra Clinics s.r.o
Rychnov nad Kněžnou, Czechia · Recruiting
CHU Strasbourg-Hopital Hautepierre
Strasbourg, France · Recruiting
CHU Tours- Hopital Bretonneau
Tours, Cedex 9, France · Recruiting
Hopital Roger Salengro - CHU Lille
Lille, Nord, France · Recruiting
Hopital Neurologique Bron
Bron, Rhone, France · Recruiting
Hôpital des Chapennes
Villeurbanne, Rhone, France · Recruiting
Azienda Ospedaliera Univerrsitaria
Naples, Napoli, Italy · Recruiting
Università Campus Bio-Medico di Roma
Roma, Roma, Italy · Recruiting
Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza, UOI Day Hospital di Neurologia
Roma, Roma, Italy · Recruiting
Institute of Mental Health
Belgrade, Serbia · Recruiting
University Clinical Center Kragujevac
Kragujevac, Serbia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.